Emerging Therapy

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Confirms Alignment with FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1-3 Years-Old

Dr Edwin Kim Receives $1-Million Grant for Novel Multi-Nut Allergy SLIT Treatment Study

FDA Approves LongBio’s Anti-IgE Antibody for Clinical Trials to Treat Food Allergy

Aravax Testing New Way to Tackle Food Allergy

Are Biologics the Future of Food Allergy Treatment? One Study Weighs Pros and Cons

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Hoping Needle-Free Intranasal Epinephrine will be Approved? Tell the FDA!

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Company Announces First Patient Dosing with Peanut Allergy Vaccine

Cancer Drug Shows Promise as Treatment for Food Allergies

Sublingual Epinephrine Faster to Maximum Concentration than Auto-Injector, Syringe

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

Your School On Our Map

Why the Lay’s Potato Chips Recall Affects EVERYONE in the Food Allergy Community